ReviewFood science & nutrition2025
Evaluating the Anti-Oxidant and Anti-Inflammatory Properties of Watercress Supplementation at Short-Term Follow-Up: A Systematic Review of Randomized Controlled Trials.
Review in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- UntargetedNutrients · 2026Trial
- Efficacy of Watercress (Antioxidants (Basel, Switzerland) · 2026Article
- Impact of Watercress Consumption on Antioxidant Defense and Oxidative Stress Among Adults with Different Levels of Exposure to Cigarette Smoke in Chiang Mai, Thailand.Antioxidants (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Watercress (WC) has been used extensively in traditional medicine for various healthcare conditions such as hypertension, hyperglycemia, arthritis, and more. This systematic review evaluates WC's antioxidant and anti-inflammatory markers in human studies. A systematic review search was conducted in PubMed, Embase, and Cochrane Library for studies reporting anti-inflammatory and anti-oxidative markers following WC supplementation, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Study variables included the number of patients, dosage/formulation of WC, mean age, and follow-up time, pre- and post-intervention antioxidant/anti-inflammatory outcomes, and complications. Seven RCTs, including 302 patients with a mean age of 47 years (23-61) and a mean follow-up time of 39 days (21-60), were included in this study. The dosage varied from 85 g/day to 750 mg/kg/day. Antioxidant parameters reported included superoxide dismutase (five studies), ferric-reducing antioxidant power (two studies), glutathione peroxidase (two studies), retinol (two studies), β-carotene (two studies), and α-tocopherol (two studies). Oxidative stress parameters included protein carbonyls (four studies), thiobarbituric acid reactive substances (two studies), malondialdehyde (two studies), nitric oxide (two studies), T-SH (two studies), and CAT (three studies). Inflammatory markers included two studies reporting on tumor necrosis factor-a (two studies) and one study reporting on interleukin-1, interleukin-6, and C-reactive protein. WC administration demonstrated improvement for most antioxidant and anti-inflammatory markers and had a strong safety profile. WC had a positive effect on anti-oxidant and anti-inflammatory markers. However, the relatively short follow-up times and heterogeneous patient demographics and formulations/dosages of WC warrant further studies to assess the benefits of WC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.